ELAN News and Press, Elanco Animal Health Incorporated From 05/23/22

Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Stifel 2022 Jaws and Paws Conference on Wednesday, June 1, 2022. Jeff Simmons, president and CEO, will participate in a fireside chat at 3:00 p.m. ET. A live audio webcast will be available in the “Events and Pres...

Soros's 13F portfolio value decreased ~12% from $7.31B to $6.57B this quarter. The number of positions decreased from 279 to 273. Soros increased Rivian and Alphabet while decreasing Liberty Broadband, D.R. Horton, and Aramark. They also increased short positions on the Nasdaq 100...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Image source: The Motley Fool. Elanco Animal Health Inc. (NYSE: ELAN) Q1 2022 Earnings Call May 09, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Elanco Animal Health Inc. (ELAN) Q1 2022 Earnings Call Transcript ...

Elanco Animal Health Incorporated (ELAN) Q1 2022 Earnings Conference Call May 9, 2022, 08:00 AM ET Company Participants Katy Grissom - Head of IR Jeffrey Simmons - CEO Todd Young - CFO Conference Call Participants Erin Wright - Morgan Stanley Michael Ryskin - BofA Securities Merrill Lynch Nat...

Shares of Elanco Animal Health (NYSE:ELAN) are down 5% in Monday morning trading after the company issued updated 2022 guidance including revenue below expectations. 2022 revenue guidance of $4.7B-~$4.76B (prior ~$4.75B-$4.8B) is below consensus of $4.77B. The company said that the ...

The following slide deck was published by Elanco Animal Health Incorporated in conjunction with their 2022 Q1 earnings call. For further details see: Elanco Animal Health Incorporated 2022 Q1 - Results - Earnings Call Presentation

Elanco press release (NYSE:ELAN): Q1 Non-GAAP EPS of $0.36 beats by $0.01. Revenue of $1.23B (-0.8% Y/Y) beats by $10M. Updating full year 2022 revenue guidance to be $4,700 to $4,755 million vs. consensus of $4.77B, due to the negative impact of foreign exchange rates; constant currency reve...

First Quarter 2022 Financial Results Revenue of $1,225 million Reported Net Income of $48 million, Adjusted Net Income of $177 million Adjusted EBITDA of $339 million or 27.7% of Revenue Reported EPS of $0.10, Adjusted EPS of $0.36 ...

Elanco Animal Health (NYSE:ELAN) has obtained the exclusive U.S. licensing rights to Bovaer, methane-reducing feed additive approved in Europe, Brazil, Chile and Australia for beef and dairy cattle. The transaction announced on Monday follows a strategic alliance with Royal DSM, under which t...